GPI-80 Defines Self-Renewal Ability in Hematopoietic Stem Cells during Human Development Scientists discovered that the glycophosphatidylinositol-anchored surface protein GPI-80 defines a subpopulation of human fetal liver hematopoietic stem/progenitor cells with self-renewal ability. [Cell Stem Cell] Abstract | Graphical Abstract | Press Release Identification of Cdca7 as a Novel Notch Transcriptional Target Involved in Hematopoietic Stem Cell Emergence Researchers found that during embryonic hematopoietic development, expression of Cdca7 is restricted to the hematopoietic clusters of the aorta, and it is strongly up-regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation in a Notch-dependent manner. [J Exp Med] Abstract Inflammatory Signaling Regulates Embryonic Hematopoietic Stem and Progenitor Cell Production Scientists show that sterile tonic inflammatory signaling regulates embryonic hematopoietic stem and progenitor cells formation. Expression profiling of progenitors with lymphoid potential and hematopoietic stem cells from aorta/gonad/mesonephros regions of midgestation mouse embryos revealed a robust innate immune/inflammatory signature. [Genes Dev] Abstract Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis In leukemic cells, investigators show constitutive activation of focal adhesion kinase (FAK) whose inhibition represses leukemogenesis. Downstream of FAK, activation of Rac1 is regulated by RacGEF Tiam1, whose inhibition prolongs the survival of leukemic mice. [Cell Rep] Full Article | Graphical Abstract Coordinate Expansion of Murine Hematopoietic and Mesenchymal Stem Cell Compartments by SHIPi Scientists show here that treatment of mice with aminosteroid inhibitors of SHIP1 (SHIPi) more than doubles the size of the adult mesenchymal stem cell compartment while simultaneously expanding the hematopoietic stem cell pool six-fold. [Stem Cells] Abstracts In Vitro Human Embryonic Stem Cell Hematopoiesis Mimics MYB-Independent Yolk Sac Hematopoiesis Since Myb was reported to be an excellent marker for hematopoietic stem cell-dependent hematopoiesis, investigators generated a MYB-eGFP reporter human embryonic stem cell line to study formation of hematopoietic progenitor cells in vitro. [Haematologica] Abstract | Full Article Hematopoietic Stem/Progenitor Cell Sources to Generate Reticulocytes for Plasmodium vivax Culture Investigators compared the production of reticulocytes using an established in vitro culture system from three different sources of hematopoietic stem/progenitor cells, i.e. umbilical cord blood, bone marrow and adult peripheral blood. [PLoS One] Full Article Co-Transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis The effects of co-transplantation of hematopoietic stem cells and mouse bone marrow-derived mesenchymal stem cells overexpressing CXCR4 (CXCR4-MSC) on CXCR4-MSC homing capacity and the reconstitution potential in lethally irradiated mice were evaluated. [Cell Biochem Biophys] Abstract An Expandable, Inducible Hemangioblast State Regulated by Fibroblast Growth Factor Investigators identified six transcription factors, Gata2, Lmo2, Mycn, Pitx2, Sox17, and Tal1, that “trap” murine cells in a proliferative state and endow them with a hemangioblast potential. [Stem Cell Rep] Full Article | Press Release CLINICAL RESEARCH Incidence, Risk Factors, and Clinical Outcome of Leukemia Relapses with Loss of the Mismatched HLA after Partially-Incompatible Hematopoietic Stem Cell Transplantation Genomic loss of the mismatched HLA is a recently described mechanism of leukemia immune escape and relapse after allogeneic hematopoietic stem cell transplantation. Investigators first evaluated its incidence, risk factors, and outcome in 233 consecutive transplants from partially HLA-mismatched related and unrelated donors. [Leukemia] Abstract Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia with Mutations in the WAS Gene To answer the question whether hematopoietic stem cell transplantation (HSCT) offers a viable therapeutic option in X-linked thrombocytopenia (XLT), researchers retrospectively investigated the outcome of HSCT in a cohort of 24 XLT patients who received HSCT at 14 transplant centers in the United States, Italy, Germany, Canada, and Japan. [J Clin Immunol] Abstract |